Charlotte's Web Holdings (CWBHF) Total Current Liabilities (2020 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Total Current Liabilities of $8.1 million for Q1 2026, down 56.19% year-over-year from $18.5 million in Q1 2025, and down 6.46% quarter-over-quarter from $8.7 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Total Current Liabilities (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Total Current Liabilities for 7 consecutive years, with $8.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 56.19% year-over-year to $8.1 million; the TTM figure through Mar 2026 stood at $8.1 million (down 56.19% YoY), while the FY2025 annual figure was $8.7 million, down 45.66% from the prior year.
- Total Current Liabilities eased to $8.1 million in Q1 2026 per CWBHF's latest filing, from $8.7 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $24.8 million in Q3 2023 and bottomed at $8.1 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $17.0 million across 5 years, with a median of $17.8 million in 2022.
- Annual changes were most pronounced in 2023 — Total Current Liabilities surged 88.49% — and 2026, when it slumped 56.19%.
- Charlotte's Web Holdings' Total Current Liabilities stood at $21.4 million in 2022, then advanced by 10.36% to $23.6 million in 2023, then plunged by 32.61% to $15.9 million in 2024, then tumbled by 45.66% to $8.7 million in 2025, then decreased by 6.46% to $8.1 million in 2026.
- Business Quant data shows CWBHF's Total Current Liabilities at $8.1 million in Q1 2026, $8.7 million in Q4 2025, and $8.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 32.59 Bn | 30.92 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - | 1.79 Bn |
| 10 | Charlotte's Web Holdings | 59.13 Mn | 45.14 Mn | 5.16 Mn | 8.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.26 Mn |
| Mar 31, 2026 | 8.10 Mn |
| Dec 31, 2025 | 8.66 Mn |
| Sep 30, 2025 | 8.87 Mn |
| Jun 30, 2025 | 10.36 Mn |
| Mar 31, 2025 | 18.49 Mn |
| Dec 31, 2024 | 15.94 Mn |
| Sep 30, 2024 | 16.48 Mn |
| Jun 30, 2024 | 18.47 Mn |
| Mar 31, 2024 | 19.63 Mn |
| Dec 31, 2023 | 23.65 Mn |
| Sep 30, 2023 | 24.78 Mn |
| Jun 30, 2023 | 22.61 Mn |
| Mar 31, 2023 | 22.62 Mn |
| Dec 31, 2022 | 21.43 Mn |
| Sep 30, 2022 | 13.15 Mn |
| Jun 30, 2022 | 17.79 Mn |
| Mar 31, 2022 | 17.79 Mn |
| Dec 31, 2021 | 20.17 Mn |
| Dec 31, 2020 | 28.87 Mn |